Disc Medicine (IRON) Amortizatization of Intangibles (2024 - 2026)
Disc Medicine's (IRON) quarterly Amortizatization of Intangibles came in at $1.1 million in Q1 2026, down 57.7% year-on-year from $2.5 million in Q1 2025, and down 34.5% on a QoQ basis from $1.6 million in Q4 2025.
Disc Medicine (IRON) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends
Disc Medicine (IRON) has 3 years of Amortizatization of Intangibles data on file, last reported at $1.1 million in Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles fell 57.7% year-over-year to $1.1 million in Q1 2026; TTM through Mar 2026 was $7.1 million, a 9.83% decrease from a year earlier, with the FY2025 full-year figure at $8.5 million, up 60.61% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $1.1 million, down from $1.6 million in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for IRON reached as high as $2.6 million in Q2 2025 and fell as low as $596000.0 in Q2 2024.
- Historically, Amortizatization of Intangibles has averaged $1.9 million across 3 years, with a median of $2.0 million in 2024.
- Across the five-year window, Amortizatization of Intangibles surged 339.77% in 2025 and plunged 57.7% in 2026, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $2.2 million in 2024, then decreased by 26.22% to $1.6 million in 2025, then sank by 34.5% to $1.1 million in 2026.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $1.1 million in Q1 2026, $1.6 million in Q4 2025, and $1.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Disc Medicine | 2.89 Bn | 2.89 Bn | - | 1.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.07 Mn |
| Mar 31, 2026 | 1.07 Mn |
| Dec 31, 2025 | 1.63 Mn |
| Dec 31, 2025 | 1.63 Mn |
| Sep 30, 2025 | 1.74 Mn |
| Sep 30, 2025 | 1.74 Mn |
| Jun 30, 2025 | 2.62 Mn |
| Jun 30, 2025 | 2.62 Mn |
| Mar 31, 2025 | 2.53 Mn |
| Mar 31, 2025 | 2.53 Mn |
| Dec 31, 2024 | 2.21 Mn |
| Dec 31, 2024 | 2.21 Mn |
| Sep 30, 2024 | 2.50 Mn |
| Sep 30, 2024 | 2.50 Mn |
| Jun 30, 2024 | 596,000.00 |
| Jun 30, 2024 | 596,000.00 |